The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Prehospital Ticagrelor in ST-Segment Elevation Myocardial Infarction
Open accessAbstract
BACKGROUND: The direct-acting platelet P2Y12 receptor antagonist ticagrelor can reduce the incidence of major adverse cardiovascular events when administered at hospital admission to patients with ST-segment elevation myocardial infarction (STEMI). Whether prehospital administration of ticagrelor can improve coronary reperfusion and the clinical outcome is unknown. METHODS: We conducted an international, multicenter, randomized, double-blind study involving 1862 patients with ongoing STEMI of less than 6 hours' duration, comparing prehospital (in the ambulance) versus in-hospital (in the catheterization laboratory) treatment with ticagrelor. The coprimary end points were the proportion of patients who did not have a 70% or greater resolution of ST-segment elevation before percutaneous coronary intervention (PCI) and the proportion of patients who did not have Thrombolysis in Myocardial Infarction flow grade 3 in the infarct-related artery at initial angiography. Secondary end points included the rates of major adverse cardiovascular events and definite stent thrombosis at 30 days. RESULTS: The median time from randomization to angiography was 48 minutes, and the median time difference between the two treatment strategies was 31 minutes. The two coprimary end points did not differ significantly between the prehospital and in-hospital groups. The absence of ST-segment elevation resolution of 70% or greater after PCI (a secondary end point) was reported for 42.5% and 47.5% of the patients, respectively. The rates of major adverse cardiovascular events did not differ significantly between the two study groups. The rates of definite stent thrombosis were lower in the prehospital group than in the in-hospital group (0% vs. 0.8% in the first 24 hours; 0.2% vs. 1.2% at 30 days). Rates of major bleeding events were low and virtually identical in the two groups, regardless of the bleeding definition used. CONCLUSIONS: Prehospital administration of ticagrelor in patients with acute STEMI appeared to be safe but did not improve pre-PCI coronary reperfusion. (Funded by AstraZeneca; ATLANTIC ClinicalTrials.gov number, NCT01347580.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
Self-citationTicagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
Self-citation2013 ESC guidelines on the management of stable coronary artery disease
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht296 · Cited by 4,510
Self-citationBraunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D., Kupersmith, J., Levin, T. N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1193 · Cited by 4,487
Authors/Task Force Members, Hamm, C. W., Bassand, J.-P., Agewall, S., Bax, J., Boersma, E., Bueno, H., Caso, P., Dudek, D., Gielen, S., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr236 · Cited by 3,080
Self-citationComparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial Infarction
Stone, G. W., Grines, C. L., Cox, D. A., Garcia, E., Tcheng, J. E., Griffin, J. J., Guagliumi, G., Stuckey, T., Turco, M., Carroll, J. D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013404 · Cited by 1,277
Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction
Montalescot, G., Barragan, P., Wittenberg, O., Ecollan, P., Elhadad, S., Villain, P., Boulenc, J.-M., Morice, M.-C., Maillard, L., Pansiéri, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442503 · Cited by 1,186
Self-citationMontalescot, G., Wiviott, S. D., Braunwald, E., Murphy, S. A., Gibson, C. M., McCabe, C. H., & Antman, E. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60441-4 · Cited by 1,068
Self-citationAnderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Chavey, W. E., Fesmire, F. M., Hochman, J. S., Levin, T. N., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.014 · Cited by 960
Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events
Bhatt, D. L., Stone, G. W., Mahaffey, K. W., Gibson, C. M., Steg, P. G., Hamm, C. W., Price, M. J., Leonardi, S., Gallup, D., Bramucci, E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300815 · Cited by 840
Self-citationFacilitated PCI in Patients with ST-Elevation Myocardial Infarction
Ellis, S. G., Tendera, M., de Belder, M. A., van Boven, A. J., Widimsky, P., Janssens, L., Andersen, H. R., Betriu, A., Savonitto, S., Adamus, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706816 · Cited by 696
Self-citationPretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes
Montalescot, G., Bolognese, L., Dudek, D., Goldstein, P., Hamm, C., Tanguay, J.-F., ten Berg, J. M., Miller, D. L., Costigan, T. M., Goedicke, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1308075 · Cited by 657
Self-citationIntravenous Platelet Blockade with Cangrelor during PCI
Bhatt, D. L., Lincoff, A. M., Gibson, C. M., Stone, G. W., McNulty, S., Montalescot, G., Kleiman, N. S., Goodman, S. G., White, H. D., Mahaffey, K. W., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908629 · Cited by 648
Self-citationMortality and Prehospital Thrombolysis for Acute Myocardial Infarction: A Meta-analysis
Morrison, L. J., Verbeek, P. R., McDonald, A. C., Sawadsky, B. V., & Cook, D. J. (2000) · JAMA · doi:10.1001/jama.283.20.2686 · Cited by 612
Shahzad, A., Kemp, I., Mars, C., Wilson, K., Roome, C., Cooper, R., Andron, M., Appleby, C., Fisher, M., Khand, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60924-7 · Cited by 543
van't Hof, A. W., ten Berg, J., Heestermans, T., Dill, T., Funck, R. C., van Werkum, W., Dambrink, J.-H. E., Suryapranata, H., van Houwelingen, G., Ottervanger, J. P., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61235-0 · Cited by 512
Self-citationSteg, P. G., James, S., Harrington, R. A., Ardissino, D., Becker, R. C., Cannon, C. P., Emanuelsson, H., Finkelstein, A., Husted, S., Katus, H., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.927582 · Cited by 507
Self-citationEarly versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes
Giugliano, R. P., White, J. A., Bode, C., Armstrong, P. W., Montalescot, G., Lewis, B. S., van `t Hof, A., Berdan, L. G., Lee, K. L., Strony, J. T., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901316 · Cited by 506
Self-citationBivalirudin Started during Emergency Transport for Primary PCI
Steg, P. G., van 't Hof, A., Hamm, C. W., Clemmensen, P., Lapostolle, F., Coste, P., Ten Berg, J., Van Grunsven, P., Eggink, G. J., Nibbe, L., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1311096 · Cited by 498
Self-citationStorey, R. F., Husted, S., Harrington, R. A., Heptinstall, S., Wilcox, R. G., Peters, G., Wickens, M., Emanuelsson, H., Gurbel, P., Grande, P., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.058 · Cited by 483
Self-citationParodi, G., Valenti, R., Bellandi, B., Migliorini, A., Marcucci, R., Comito, V., Carrabba, N., Santini, A., Gensini, G. F., Abbate, R., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.024 · Cited by 436
Mehran, R., Lansky, A. J., Witzenbichler, B., Guagliumi, G., Peruga, J. Z., Brodie, B. R., Dudek, D., Kornowski, R., Hartmann, F., Gersh, B. J., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61484-7 · Cited by 418
Alexopoulos, D., Xanthopoulou, I., Gkizas, V., Kassimis, G., Theodoropoulos, K. C., Makris, G., Koutsogiannis, N., Damelou, A., Tsigkas, G., Davlouros, P., et al. (2012) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.112.972323 · Cited by 396
Storey, R. F., Angiolillo, D. J., Patil, S. B., Desai, B., Ecob, R., Husted, S., Emanuelsson, H., Cannon, C. P., Becker, R. C., & Wallentin, L. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.100 · Cited by 373
Self-citationStone, G. W., Bertrand, M. E., Moses, J. W., Ohman, E. M., Lincoff, A. M., Ware, J. H., Pocock, S. J., McLaurin, B. T., Cox, D. A., Jafar, M. Z., et al. (2007) · JAMA · doi:10.1001/jama.297.6.591 · Cited by 299
Montalescot, G., Borentain, M., Payot, L., Collet, J., & Thomas, D. (2004) · JAMA · doi:10.1001/jama.292.3.362 · Cited by 286
Self-citationDe Luca, G., Navarese, E., & Marino, P. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp118 · Cited by 252
Lindholm, D., Varenhorst, C., Cannon, C. P., Harrington, R. A., Himmelmann, A., Maya, J., Husted, S., Steg, P. G., Cornel, J. H., Storey, R. F., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu160 · Cited by 208
Self-citationBellemain-Appaix, A., O’Connor, S. A., Silvain, J., Cucherat, M., Beygui, F., Barthélémy, O., Collet, J.-P., Jacq, L., Bernasconi, F., Montalescot, G., et al. (2012) · JAMA · doi:10.1001/jama.2012.50788 · Cited by 204
Self-citationten Berg, J. M., van 't Hof, A. W. J., Dill, T., Heestermans, T., van Werkum, J. W., Mosterd, A., van Houwelingen, G., Koopmans, P. C., Stella, P. R., Boersma, E., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.091 · Cited by 187
Self-citationValgimigli, M., Tebaldi, M., Campo, G., Gambetti, S., Bristot, L., Monti, M., Parrinello, G., & Ferrari, R. (2012) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2012.01.006 · Cited by 173
De Luca, G., Gibson, C. M., Bellandi, F., Murphy, S., Maioli, M., Noc, M., Zeymer, U., Dudek, D., Arntz, H.-R., Zorman, S., et al. (2008) · Heart · doi:10.1136/hrt.2008.141648 · Cited by 170
Self-citationStent Thrombosis With Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes
Steg, P. G., Harrington, R. A., Emanuelsson, H., Katus, H. A., Mahaffey, K. W., Meier, B., Storey, R. F., WOJDYLA, D. M., Lewis, B. S., Maurer, G., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.002589 · Cited by 134
Self-citationZeymer, U., Arntz, H.-R., Mark, B., Fichtlscherer, S., Werner, G. S., Schoeller, R., Zahn, R., Diller, F., Darius, H., Dill, T., et al. (2011) · Clinical Research in Cardiology · doi:10.1007/s00392-011-0393-1 · Cited by 131
Self-citationNew P2Y12Inhibitors Versus Clopidogrel in Percutaneous Coronary Intervention
Bellemain-Appaix, A., Brieger, D. B., Beygui, F., Silvain, J., Peña, A., Cayla, G., Barthélémy, O., Collet, J., & Montalescot, G. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.07.012 · Cited by 112
Self-citationWesterhout, C. M., Bonnefoy‐Cudraz, E., Welsh, R. C., Steg, P. G., Boutitie, F., & Armstrong, P. W. (2011) · American Heart Journal · doi:10.1016/j.ahj.2010.10.033 · Cited by 102
Montalescot, G., Lassen, J. F., Hamm, C. W., Lapostolle, F., Silvain, J., ten Berg, J. M., Cantor, W. J., Goodman, S. G., Licour, M., Tsatsaris, A., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2012.12.015 · Cited by 50
Self-citationCirculation: Clinical Summaries
(2013) · Circulation · doi:10.1161/cir.0b013e31828987e5 · Cited by 49
Cohen, M. V., & Downey, J. M. (2013) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248413508465 · Cited by 42
Deeks, E. D. (2011) · Drugs · doi:10.2165/11206850-000000000-00000 · Cited by 34
Cited by
Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728
Self-citation2018 ESC/EACTS guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy394 · Cited by 7,167
Self-citation2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad191 · Cited by 5,333
Self-citationValgimigli, M., Bueno, H., Byrne, R. A., Collet, J.-P., Costa, F., Jeppsson, A., Jüni, P., Kastrati, A., Kolh, P., Mauri, L., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx419 · Cited by 2,987
Self-citation2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
Lawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.09.006 · Cited by 1,558
Metadata
- Authors
- Montalescot, G., van 't Hof, A. W., Lapostolle, F., Silvain, J., Lassen, J. F., Bolognese, L., Cantor, W. J., Cequier, Á., Chettibi, M., Goodman, S. G., Hammett, C. J., Huber, K., Janzon, M., Merkely, B., Storey, R. F., Zeymer, U., Stibbe, O., Ecollan, P., Heutz, W. M. J. M., Swahn, E., Collet, J.-P., Willems, F. F., Baradat, C., Licour, M., Tsatsaris, A., Vicaut, E., & Hamm, C. W.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-09-11
- Volume
- 371
- Issue
- 11
- Pages
- 1016-1027
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2125043491
- Cited by
- 661
- References
- 41
- FWCI
- 55.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.